Showing results (471-480 of 760) with videos related to

Sort By:
Pageof 76
American Journal of Hematology|June 2, 2011
A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myelomaIrene M Ghobrial, Nikhil C Munshi, Brianna N Harris, et al.
Molecular Cancer Therapeutics|January 17, 2012
Molecular and cellular effects of NEDD8-activating enzyme inhibition in myelomaDouglas W McMillin, Hannah M Jacobs, Jake E Delmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 ExpressionLijie Xing, Su Wang, Jiye Liu, et al.
Cancer Cell|October 6, 2009
Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic targetDharminder Chauhan, Ajita V Singh, Mohan Brahmandam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myelomaClaire Fabre, Naoya Mimura, Kathryn Bobb, et al.
Blood|January 24, 2012
Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantationMelinda A Biernacki, Yu-tzu Tai, Guang Lan Zhang, et al.
Blood|May 7, 2009
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myelomaMariateresa Fulciniti, Pierfrancesco Tassone, Teru Hideshima, et al.
Pageof 76